Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 17;13(1):9021.
doi: 10.4081/dr.2021.9021. eCollection 2021 Mar 18.

Diffuse cutaneous mastocytosis masquerading as linear IgA bullous dermatosis of childhood

Tuntas Rayinda  1 , Dyah Ayu Mira Oktarina  1 , Retno Danarti  1
Affiliations

Diffuse cutaneous mastocytosis masquerading as linear IgA bullous dermatosis of childhood

Tuntas Rayinda et al. Dermatol Reports. .

Abstract

Diffuse cutaneous mastocytosis is a rare form of cutaneous mastocytosis that can appear in heterogeneous clinical presentations, including eruption of papules, erythematous plaques, blisters, and erythroderma. We report a 1.5- year-old boy who presented with itchy wheals and blisters spreading on his body. The patient was initially managed as a linear IgA bullous dermatosis of childhood (LABD) because of the similarity of clinical symptoms and the presenting of linear IgA deposits at the basement membrane. Due to the development of urticarial plaque after the resolution of the blisters, the diagnosis of diffuse cutaneous mastocytosis was made based on clinical, histopathological (hematoxylin-eosin, Giemsa, and toluidine blue staining), and direct immunofluorescent examinations (IgA, IgG, IgM, C3). The symptoms were improved following antihistamines and oral corticosteroid treatment.

Keywords: Cutaneous mastocytosis; bullous mastocytosis; chronic bullous disease of childhood; linear IgA dermatosis of childhood.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no potential conflict of interest.

Figures

Figure 1.
Figure 1.
Clinical picture of the patient at initial visit: blisters and erosion distributed on the trunk (A), and the development of new urticarial plaques after blisters resolution (B).
Figure 2.
Figure 2.
Histopathology staining with hematoxylin-eosin (A1, A2), Toluidine blue (B1, B2), and Giemsa (C1, C2), showed massive infiltration of mast cells in the epidermis and dermis.
Figure 3.
Figure 3.
Immunofluorescent staining showed linear Immunoglobulin A (IgA) deposition in the basement membrane.
See this image and copyright information in PMC

References

    1. Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis : a review of 180 Patients. Isr Med Assoc J 2005;7:320-2. - PubMed
    1. Nettleship E. Rare form of urticaria. Br Med J 1869;2:323–4.
    1. Brockow K. Epidemiology, prognosis, and risk factors in mastocytosis. Immunol Allergy Clin North Am 2014;34:283–95. - PubMed
    1. Méni C, Bruneau J, Georgin-Lavialle S, et al. Paediatric mastocytosis: a systematic review of 1747 cases. Br J Dermatol 2015;172:642–51. - PubMed
    1. Neri I, Guareschi E, Guerrini V, Patrizi A. Familial teleangiectasia macularis eruptiva perstans. Pediatr Dermatol 2005;22:488–9. - PubMed

LinkOut - more resources